Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Immune Monitoring Using mRNA-Transfected Dendritic Cells

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Full-Length Open Reading Frame Amplification of Hepatitis C Virus

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. In Vitro Neutralization Assay Using Cultured Hepatitis C Virus

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Imaging N-Acyl Homoserine Lactone Quorum Sensing In Vivo

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. In Vitro Maturation and Culture of Human Oocytes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Large Porcine Model of Profound Acute Ischemic Cardiogenic Shock

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The real-world impact of modern treatments on the survival of patients with metastatic melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Principles of adoptive T cell therapy in cancer

    Research output: Contribution to journalReviewResearchpeer-review

  5. Immunoprofiles of colorectal cancer from Lynch syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Dendritic cells are known to be the most potent antigen presenting cell in the immune system and are used as cellular adjuvants in therapeutic anticancer vaccines using various tumor-associated antigens or their derivatives. One way of loading antigen into the dendritic cells is by mRNA electroporation, ensuring presentation of antigen through major histocompatibility complex I and potentially activating T cells, enabling them to kill the tumor cells. Despite extensive research in the field, only one dendritic cell-based vaccine has been approved. There is therefore a great need to elucidate and understand the immunological impact of dendritic cell vaccination in order to improve clinical benefit. In this chapter, we describe a method for performing immune monitoring using peripheral blood mononuclear cells and autologous dendritic cells transfected with tumor-associated antigen-encoding mRNA.

Original languageEnglish
JournalMethods in molecular biology (Clifton, N.J.)
Volume1428
Pages (from-to)245-59
Number of pages15
ISSN1064-3745
DOIs
Publication statusPublished - 2016

    Research areas

  • Journal Article

ID: 49640145